Physician profile
Stuart G Clark
NPI 1831532555
$2,448.48
in general payments reported to CMS, 2019-2025
22 companies · $545 in 2025
The $545 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $31.23 · 2021: $60.84 · 2022: $441 · 2023: $544 · 2024: $659 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $491.88 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $425.45 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Pfizer INC. | $236.23 | 2023-2025 | |
| Tris Pharma INC | $204.19 | 2021-2023 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $165.81 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Ironshore Pharmaceuticals INC. | $139.69 | 2019-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $116.78 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $87.50 | 2022-2024 | Qelbree |
| Collegium Pharmaceutical, INC. | $76.79 | 2025 | Jornay Pm |
| Phadia US INC. | $76.38 | 2021-2023 | Immunocap |
| Sanofi-Aventis U.S. LLC | $59.91 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.28 | 2022 | |
| Neos Therapeutics, LP | $54.72 | 2019-2024 | Cotempla Xr-Odt |
| Aytu Biopharma, INC. | $50.26 | 2022-2023 | Karbinal |
| Astrazeneca Pharmaceuticals LP | $42.13 | 2024 | Flumist Quadrivalent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $39.47 | 2024-2025 | Zoryve |
| Rhodes Pharmaceuticals L.P. | $30.76 | 2019 | |
| Hologic Sales and Service, LLC | $28.01 | 2023 | Aptima |
| Sobi, INC | $25.29 | 2023 | |
| Adlon Therapeutics L.P. | $19.71 | 2020 | |
| Kaleo, INC. | $11.22 | 2019 | |
| Genentech USA, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.